SEBI approves Piramal Pharma’s Rs 1,050-crore rights issue
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The business and product range of Ipca and that of Unichem complements each others business and product range
Natural Capsules Limited's shareholding will be reduced to 89.99%
There is a fast resurgence in the transplant activities post COVID
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
Subscribe To Our Newsletter & Stay Updated